SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001718108-20-000015
Filing Date
2020-11-10
Accepted
2020-11-10 06:07:10
Documents
69
Period of Report
2020-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q surf-20200930.htm   iXBRL 10-Q 1271714
2 EX-31.1 surf-09302020xexx311.htm EX-31.1 9869
3 EX-31.2 surf-09302020xexx312.htm EX-31.2 10016
4 EX-32.1 surf-09302020xexx321.htm EX-32.1 4850
5 EX-32.2 surf-09302020xexx322.htm EX-32.2 4864
  Complete submission text file 0001718108-20-000015.txt   6179613

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT surf-20200930.xsd EX-101.SCH 43110
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT surf-20200930_cal.xml EX-101.CAL 70463
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT surf-20200930_def.xml EX-101.DEF 260976
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT surf-20200930_lab.xml EX-101.LAB 591175
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT surf-20200930_pre.xml EX-101.PRE 388823
11 EXTRACTED XBRL INSTANCE DOCUMENT surf-20200930_htm.xml XML 989403
Mailing Address 50 HAMPSHIRE STREET, 8TH FLOOR CAMBRIDGE MA 02139
Business Address 50 HAMPSHIRE STREET, 8TH FLOOR CAMBRIDGE MA 02139 617-714-4096
Surface Oncology, Inc. (Filer) CIK: 0001718108 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38459 | Film No.: 201299518
SIC: 2836 Biological Products, (No Diagnostic Substances)